From the Campbell University School of Osteopathic Medicine.
Department of Orthopaedic Surgery, University of Pittsburgh.
Plast Reconstr Surg. 2024 Feb 1;153(2):423-429. doi: 10.1097/PRS.0000000000010773. Epub 2023 May 31.
It remains unclear whether physiologic differences exist in musculoskeletal ultrasound nerve measurements when comparing bilateral and unilateral carpal tunnel syndrome (CTS) patients. Similarly, the influence of body mass index on CTS severity is not well characterized.
Unilateral and bilateral CTS patients were seen from October of 2014 to February of 2021. Obese and nonobese CTS patients were compared. Median nerve cross-sectional area (CSA), Boston Carpal Tunnel Syndrome Questionnaire (BCTSQ), and six-item Carpal Tunnel Symptom Score (CTS-6) measures were obtained. Nerve conduction studies recorded distal motor latency (DML) and distal sensory latency (DSL). Statistical analysis used Wilcoxon signed rank testing for paired continuous variables, Mann-Whitney U testing for nonpaired continuous variables, and chi-square testing for continuous variables, with a significance level of P < 0.05.
A total of 109 (218 nerves) bilateral and 112 (112 nerves) unilateral CTS patients were reviewed. Bilateral patients had larger median nerve CSAs on their more symptomatic side, when defined by BCTSQ score ( P < 0.0001), CTS-6 score ( P < 0.0001), DML ( P < 0.0001), and DSL ( P < 0.01). Bilateral patients also had higher symptom severity scale ( P < 0.01) and DSL ( P < 0.001) outcomes compared with unilateral patients. Obese patients had higher median nerve CSA ( P < 0.01), prolonged DML, and prolonged DSL ( P < 0.0001) values despite similar CTS severity (BCTSQ and CTS-6).
Ultrasound identifies the more symptomatic side in bilateral patients, which correlates with increasing severity (NCS and BCTSQ). Obesity increases median nerve CSA and prolongs nerve conduction studies without influencing CTS severity. This information can be used when considering which diagnostic test to order for CTS.
目前尚不清楚在比较双侧和单侧腕管综合征(CTS)患者时,肌肉骨骼超声神经测量是否存在生理差异。同样,身体质量指数(BMI)对 CTS 严重程度的影响也尚未得到很好的描述。
2014 年 10 月至 2021 年 2 月期间,我们对单侧和双侧 CTS 患者进行了观察。比较了肥胖和非肥胖的 CTS 患者。获取正中神经横截面积(CSA)、波士顿腕管综合征问卷(BCTSQ)和六分量表腕管症状评分(CTS-6)的测量值。神经传导研究记录了远端运动潜伏期(DML)和远端感觉潜伏期(DSL)。使用 Wilcoxon 符号秩检验对配对连续变量、Mann-Whitney U 检验对非配对连续变量和卡方检验对连续变量进行统计分析,显著性水平为 P < 0.05。
共回顾了 109 例(218 根神经)双侧和 112 例(112 根神经)单侧 CTS 患者。当根据 BCTSQ 评分( P < 0.0001)、CTS-6 评分( P < 0.0001)、DML( P < 0.0001)和 DSL( P < 0.01)定义更具症状的一侧时,双侧患者的正中神经 CSA 更大。与单侧患者相比,双侧患者的症状严重程度量表( P < 0.01)和 DSL( P < 0.001)结果更高。尽管 CTS 严重程度相似(BCTSQ 和 CTS-6),但肥胖患者的正中神经 CSA 更高( P < 0.01)、DML 延长和 DSL 延长( P < 0.0001)。
超声可识别双侧患者的更具症状侧,这与严重程度的增加(NCS 和 BCTSQ)相关。肥胖增加了正中神经 CSA 并延长了神经传导研究,而不影响 CTS 严重程度。在考虑为 CTS 订购哪种诊断测试时,可以使用这些信息。